News and Info

Welcome to the News and Information section of the ECOG-ACRIN Cancer Research Group website. The materials posted in this section are intended to keep constituents informed of the latest news and activities of the organization. The information below includes press releases, announcements, media advisories, and links to news articles.

We welcome inquiries from members of the press regarding the information posted on this website. To place a media inquiry, contact the Office of Communications.


Latest News

May 17, 2023

Press Release: ECOG-ACRIN announces the recipients of its 2023 scientific leadership and mentorship awards

May 11, 2023

Press Release: Historic achievement for the ongoing InPACT penile cancer trial—100 patients enrolled thus far, the most ever to a prospective study in this extremely rare disease

April 29, 2023

A TAILORx post hoc analysis is the first to show racial and ethnic differences in locoregional breast cancer recurrence

April 28, 2023

JAMA Surgery publishes TAILORx analysis showing that racial and ethnic differences in locoregional breast cancer recurrence patterns are prevalent even in a clinical trial population with similar access to care

April 26, 2023

Two new studies shed light on cancer detection in dense breasts as researchers emphasize the need for the TMIST trial

April 26, 2023

An AI algorithm may help better guide oropharynx cancer treatment

April 21, 2023

Lancet Digital Health publishes the first validation of a CT-based deep learning tool for pre-treatment identification of head and neck cancer patients with high-risk, aggressive disease (in the context of the E3311 trial)

April 19, 2023

The March/April 2023 News from ECOG-ACRIN blog is now available

April 7, 2023

American College of Radiology (ACR) leader highlights TMIST mammography trial in testimony supporting NIH funding increase

April 6, 2023

E1411 study chair Mitchell Smith discusses the use of ibrutinib for patients with previously treated mantle cell lymphoma

March 23, 2023

The Spring 2023 advocacy blog Considering Clinical Trials is now available

March 21, 2023

In this video interview, Dr. Neha Vapiwala discusses the INDICATE (EA8191) trial and changing the trajectory of prostate cancer through radiation and imaging techniques

March 8, 2023

The ComboMATCH patient registration trial and three treatment trials are now open

February 27, 2023

The TAILORx trial continues to provide reassurance that many women with early breast cancer can safely forego chemotherapy

February 23, 2023

A focus on the DREAMseq trial reveals data-driven clinical insights into the selection of first-line treatment options for patients with BRAF-mutated metastatic melanoma

February 15, 2023

A participant in the E1910 trial shares her experience in a Penn Medicine feature story with her hematologist, Dr. Selina Luger

February 15, 2023

ASCO Living Guideline says ‘no’ to anti-VEGF-chemo combo in non-small cell lung cancer without driver alterations, based on data from the E5508 trial

February 10, 2023

The January/February 2023 News from ECOG-ACRIN blog is now available

February 10, 2023

ECOG-ACRIN announces the Remarkable Mentor to Women in Oncology Award (nominations are due March 9)

February 9, 2023

The application period is now open for Spring Meeting Attendance Awards for minority trainees

 
ECOG-ACRIN Cancer Research Group